“The rating reflects SBHD’s continued strong overall financial profile as evidenced by operating performance and key balance metrics that are consistent with the ‘AA’ rating,” said S&P analyst Stephen Infranco.
The agency also affirmed the following ratings on HSHS’ bonds, including:
- “AA” rating on its series 2016A bonds
- “AA” rating on its series 2007 bonds
- “AA” rating on its series 2009 bonds
- “AA” rating on its series 2015 bonds
- “AA” rating on its series 2016 bonds
The outlook is stable, reflecting S&P’s expectation the health system will maintain its solid enterprise profile and continue to generate strong earnings.
More articles on healthcare finance:
Fitch affirms ‘BB’ rating on Marietta Memorial Health System’s bonds
S&P assigns ‘AA-/A-+’ rating to Hospital Sisters Health System’s bonds
Moody’s affirms ‘Aa3’ rating on Partners HealthCare’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
